Intravenous immunoglobulin therapy for dystrophic calcinosis cutis: Unreliable in our hands

Archives of Dermatology

Volumn 145, Issue 3, 2009, Pages 334-

  Kalajian, Andrew H ^a   Perryman, Jennifer H ^a   Callen, Jeffrey P ^a  

^a Ste 200 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; DILTIAZEM; HYDROXYCHLOROQUINE SULFATE; IMMUNOGLOBULIN;

ADULT; CALCINOSIS; CASE REPORT; DERMATOMYOSITIS; DISEASE COURSE; DYSTROPHIC CALCINOSIS CUTIS; FEMALE; HUMAN; NOTE; PRIORITY JOURNAL; SYNDROME CREST; TREATMENT FAILURE;

CALCINOSIS; CREST SYNDROME; DERMATOMYOSITIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; SKIN DISEASES;

EID: 78650760190     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2008.620     Document Type: Note

References (2)

1. Schanz S, Ulmer A, Fierlbeck G. Response of dystrophic calcification to intravenous immunoglobulin. Arch Dermatol. 2008;144(5):585-587.
2. Boulman B, Slobodin G, Rozenbaum M, Rosner I. Calcinosis in rheumatic diseases. Semin Arthritis Rheum. 2005;34(6):805-812.